British Design Fund’s Post

Congratulations to the Top 4 student ventures advancing to the Final Round of the 2024 Dempsey Startup Competition: BioLegacy CivicImpact.ai Joy Bucket MoodRoom BioLegacy aims to extend donor organ viability from 24 hours to years by utilizing patent-pending organ cryopreservation and electromagnetic rewarming technologies, while working with clinical partners to save more lives. CivicImpact.ai’s RFPGo, a GenAI-powered tool, aims to transform the documents cities use in the public procurement process to create a virtuous flywheel that creates more business opportunities, increases market competition, and improves the quality of goods and services delivered to all citizens. Joy Bucket created an affordable, clinical grade wearable health technology for safe and healthy pregnancies with the goal of empowering pregnant mothers against rising maternal mortality and morbidity in the United States. MoodRoom is a virtual, mental health and dialectical behavior therapy toolkit for managing mood and mental disorders, negative thought patterns, suicidal ideation, self-harm, and substance abuse. #UWDempseyStartup

Excited to announce Team8's latest investment - OneStep, which has developed a truly transformational digital health technology! Using a single sensor in your smartphone, OneStep can measure gait, the manner a person walks, at a level of accuracy and granularity previously only available when using expensive gait labs found in clinical settings. This enables clinicians to easily monitor patients both remotely and in clinic, to track a wide range of conditions like orthopedic issues and cognitive deterioration such as Parkinson or Alzheimer. We're proud to be co-leading OneStep's B-round with Vintage Investment Partners (Shira Eting) and join former investors Itay Rand (10D ), Michael Eisenberg (Aleph) and Jonathan Friedman (LionBird). This latest round brings the company's total funding to $36M. Tomer Shussman, Yuval Naveh, Shahar Davidson and the team - excited to join forces to achieve your vision of making gait as valuable as a blood test and as easy as using a bathroom scale! A huge thanks to Sarit Firon and the Team8 Health team (Assaf Mischari, Varda Shalev, Dror Grof) for making this investment happen. Read more about OneStep in the interview Tomer Shussman and I gave to Axios: https://lnkd.in/ddqUnb6r #digitalhealth #vc #venturecapital #startup #gait #israel

Are you going to JPM Conference this January? I’m excited to invite you to discover a group of cutting-edge Israeli health tech startups making waves in the industry. Through our organization, the CICC - California Israel Chamber of Commerce, we’re hosting these innovators at our San Francisco Lounge during the JPM Conference this January. These startups are developing breakthrough solutions and addressing some of healthcare’s most pressing challenges. Simply drop me a line if you want to meet with any of them. Innosphere - a wearable brain stimulation — for the treatment of pediatric ADHD Nano24  - a clinical-stage biotech company developing the next generation of immune-modulators (EXO-CD24) Neteera - FDA-cleared solution that monitors vital signs and behavioral parameters OphtiMed Rx - pioneering treatments for dry Age-Related Macular Degeneration (AMD), a top cause of vision loss worldwide PhaseV - enable de risking clinical development and increase the efficiency and success rates of clinical trials PregnanTech - developed the LIONESS™, a first-of-its-kind device designed to reduce the rate of spontaneous preterm births 📅When? January 13-15, 2025 📌Where? Israel Lounge, San Francisco #healthtech #investmentopportunity #medtech #biotech

🚀 Exciting News from RehabSwift! 🚀 We are thrilled to announce that our groundbreaking study on the personalised brain-computer interface therapy for stroke survivors has been published in the Proceedings of the National Academy of Science (PNAS Nexus)! At RehabSwift, we are dedicated to revolutionising stroke rehabilitation. Our innovative system translates imagined hand movements into real-time actions using mechanical feedback, significantly improving hand mobility for stroke survivors. Over 18 sessions, participants demonstrated remarkable progress in key areas such as grip and pinch strength, reaction time, and overall hand function. Key highlights of our study include: >Personalised therapy that optimises the part of the brain to focus on, the best feature of the brain activity, and feedback timing. >Significant improvements in motor function and sensory feedback. >Positive feedback from participants who achieved their mobility goals. Based at ThincLab, The University of Adelaide's startup incubator, RehabSwift is a spin-off from the University of Adelaide, building on the pioneering PhD research of our founder, Sam Darvishi, on feedback optimisation for restorative brain-computer interfaces. We are immensely proud of our team's dedication and the impact our technology is making in the field of stroke rehabilitation. Stay tuned for more updates as we continue to innovate and improve lives. 👉 Read more about our study and its outcomes here: https://lnkd.in/getiZxDE #StrokeRehabilitation #BrainComputerInterface #RehabSwift #Innovation #Healthcare #MedTech #Neurotech #Research #StrokeSurvivors #PersonalizedMedicine #Adelaide #SouthAustralia

📖Ethnocare's Story 12 years ago, the mother of one of our co-founder underwent a bi-lateral amputation. Throughout her rehabilitation journey, she faced significant discomfort due to the limitations of existing prosthetic devices. Louis, having grown up alongside his mother, understood that by driving innovation through a user-centered approach, we could make a profound impact on people's lives. In 2019, our co-founders completed an Ethnographic Research in collaboration with five rehabilitation centers, involving over 30 healthcare professionals and patients. The objective was to focus on gaining a deep understanding of the prosthetic ecosystem and gain insights into the lives of amputees. We’ve identified the unmet clinical needs and propose an innovative solution that could genuinely benefit the users : The Overlay. At Ethnocare, our goal remain simple yet powerful: to redefine people's mobility.

🚀 Exciting news! Noah Labs, based in Berlin, has raised $3.2 million led by Nina Capital to enhance their AI-powered Ark software for heart failure telemonitoring. This funding will also support research into voice analysis for early detection. Thrilled to see their impact on cardiovascular care! ♥️ 💡 https://lnkd.in/d-XfMcCa #AIHealthTech #CardiovascularCare #HealthInnovation #Telemedicine #VoiceAnalysis #BerlinStartups #berlinofficeusa

CergenX is pleased to announce the first step in forming its advisory board with the appointment of Neil Campbell as an advisor. Neil brings over 30 years of expertise in the MedTech industry, with a specialised focus on products aimed at diagnosing and treating newborn brain conditions since 2003. Most recently, Neil served as CEO of Inspiration Healthcare Group PLC, where he successfully led the company through a period of significant growth and innovation. As an advisor to the Board, Neil will provide strategic direction on the commercialisation of Wave, CergenX’s flagship device. Wave leverages CergenX’s cutting-edge AI algorithms to identify newborns most at risk of brain injury with speed and precision. Jason Mowles, CEO of CergenX, said: “We are delighted to welcome someone of Neil’s calibre to the advisory board. His deep experience in scaling startups and bringing groundbreaking neonatal technologies to market will be invaluable as we advance to the next phase of our journey.” Neil Campbell commented: “I have been consistently impressed by the progress CergenX has made, as well as the passion and expertise of its team. I’m excited to support the commercial rollout of this transformative technology, which has the potential to redefine the future of newborn brain health.” #MedTechInnovation #AiForGood #AIinHealthcare

Unveiling the Secrets of Cardiac Health: Dyxin.com (Domain for Sale) Dyxin.com is a unique and intriguing domain name that sparks curiosity and hints at scientific discovery. It's perfect for a business or organization focused on: Cardiac Research & Development: Companies or research institutions exploring new treatments, diagnostics, or technologies related to heart health. Cardiovascular Health Advocacy & Education: Non-profit organizations or platforms raising awareness about heart disease prevention and management. Personalized Medicine & Genomics: Businesses specializing in genetic testing or personalized approaches to cardiovascular health. Why Dyxin.com? Memorable & Brandable: Short, easy to remember, and visually striking, leaving a lasting impression on potential audiences. Scientific Intrigue: The name "Dixin" subtly references "Lmcd1/Dyxin," a protein associated with heart function, sparking curiosity in the medical field. Versatility: While hinting at the scientific aspect, "Dixin" can be interpreted in various ways, allowing you to craft a unique brand story. SEO Potential: This unique domain name can improve search engine ranking for relevant keywords like "cardiac health," "heart disease," etc. Dyxin.com offers a powerful platform to establish yourself as a leader in the field of cardiovascular health. Secure this one-of-a-kind domain and make a lasting impact on the lives of millions. #Dixin #CardiacHealth #Research #HeartDisease #DomainForSale

🌟 Excited to share that we are now ready for prototype testing! If you or anyone you know has a motor impairment that affects their upper limb mobility (especially hand mobility), please read or share this post! 🧠💪 #Innovation #Rehabilitation #Research #HealthTech #MakingADifference

When you’re talking to one the founding fathers of pulse field ablation, you know you’re in for a real whirlwind of wisdom. Dr. Steven Mickelsen is a board-certified electrophysiologist who invented a pulsed electric field system and founded FARAPULSE in 2012. Ten years later, he is back at it again, with the founding of Field Medical, as he looks to continue the crusade for superior cardiac ablation procedures. This discussion delves deep into the anatomical anomalies that ablation looks to tackle. Steven masterfully guides through the depths of the heart’s chambers and the limitations of today’s techniques. Through reverse engineering the problem, Field Medical is bringing new possibilities to tackling the underserved space of ventricular arrhythmia ablation. From the outset, Steven’s knowledge makes this a truly insightful summary of all things pulsed field ablation related, with a good sprinkling of entrepreneurial sagacity. Nearly every innovative startup hones in on a true unmet need to get started, and Field Medical’s blue ocean opportunity in VT makes this episode one that will be sure to leave you informed and inspired. https://lnkd.in/eUwrx7-v If you're heading to the VT Symposium in New York, then be sure to check out this great event the Field Medical team is hosting Event Details: Theme: PFA in the Ventricle Date: Friday, October 11th Time: 6:30 PM (Discussion starts at 7:00 PM) Location: Gage & Tollner (372 Fulton St, Brooklyn, NY 11201) Special Guests: Dr. Vivek Reddy Dr. Roderick Tung Dr. Steven Mickelsen (giving a short talk on the biophysics of PFA) And others! Join colleagues for an engaging evening where esteemed guests will share their insights and experiences with PFA as a pioneering energy source in the management of ventricular arrhythmias, as well as also devling into the biophysics behind Field Medical's innovative technology. Wine and hors d'oeuvres will be provided for your enjoyment. Please just RSVP to Alysse@FieldMedicalinc.com to secure your spot. #VentricularArrhythmias #VT #PulsedFieldAblation #PFA #Medtech #Startups #Networking #KeepInnovating Kyle Kruse 🚀, Marlou Janssen, Mark Wisniewski, Oskar Marus D., Alysse Bellinghausen, Megan M. Brandt, David Jacques, Michelle Kennefick, Bart Schade, Eduardo Jimenez, Roya Kamali, PhD., Kyle Walberg, Jonathan Salas, CEPS, Ryan Bone, Kylam Doan, Christy Mescher, Melanie Neumann-Huon, David Conger, Haider Al Taii, Jose Osorio, Ken Stein, Khaldoun Tarakji, MD MPH, Albert M Kim, Dan Musat, Ravi Shah, Athanasios Thomaides, Daniel Musikantow, Shanti Bansal, M.D., Ali Sovari, MD,FACC,FHRS, Alisa Niksch, Abhishek Maan, Amit J. Shanker, MD, Anusha Dwivedi, Anne Kroman.